Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/15/24 16:15 | 3/13/24 | SKYE | Health | Drug | Pharmaceutical Preparations | 5Am Partners Vii, LLC | CA | T | P | 4,500 | 10.00 | 0 | 450 | 5 | 10,180 | I | |||||||||||||||
2/2/24 16:32 | 1/31/24 | SKYE | Health | Drug | Pharmaceutical Preparations | 5Am Partners Vii, LLC | CA | T | P | 12,026 | 2.31 | 0 | 5,206 | 115 | 9,730 | I | |||||||||||||||
8/31/23 11:26 | 8/29/23 | SKYE | Health | Drug | Pharmaceutical Preparations | Dhillon Punit | CA | DO | CEO | P.ad | 16 | 0.0187 | 0 | 881 | 3 | 28,020 | D | ||||||||||||||
8/29/23 18:39 | 8/29/23 | SKYE | Health | Drug | Pharmaceutical Preparations | Dhillon Punit | CA | DO | CEO | P.d | 16 | 0.0187 | 0 | 881 | 2 | 41,555 | D | ||||||||||||||
8/11/20 14:53 | 8/7/20 | EMBI | Health | Drug | Pharmaceutical Preparations | Dhillon Punit | CA | DO | CEO | P.ed | 100 | 0.1000 | 0 | 1,000 | New | 1,000 | D | ||||||||||||||
8/11/20 14:52 | 8/7/20 | EMBI | Health | Drug | Pharmaceutical Preparations | Heppell James L | CA | D | P.ed | 50 | 0.1000 | 0 | 500 | New | 500 | D | |||||||||||||||
2/21/18 16:32 | 2/16/18 | NMUS | Health | Drug | Pharmaceutical Preparations | Emerald Health Sciences Inc. | A1 | T | P.d | 0 | 0.00 | 0 | 15,000 | 63 | 39,000 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |